CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,835,018
- in 1 filing
Net −$21,835,018. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-16 | Booth Bruce Director | Sale 10b5-1 | −45,117 | $31.69 | $1.4M | 2,565,472 |
| 2025-10-16 | Booth Bruce Director | Sale 10b5-1 | −9,470 | $31.69 | $300K | 740,390 |
| 2025-10-16 | Booth Bruce Director | Sale 10b5-1 | −73,296 | $32.84 | $2.4M | 2,492,176 |
| 2025-10-16 | Booth Bruce Director | Sale 10b5-1 | −15,384 | $32.84 | $505K | 725,006 |
| 2025-10-16 | Booth Bruce Director | Sale 10b5-1 | −12,888 | $33.38 | $430K | 2,479,288 |
| 2025-10-16 | Booth Bruce Director | Sale 10b5-1 | −2,705 | $33.38 | $90K | 722,301 |
| 2025-10-16 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +10,225 | $6.11 | $62K | 557,568 |
| 2025-10-16 | Cloonan Michael President & CEO | Sale 10b5-1 | −10,225 | $31.46 | $322K | 547,343 |
| 2025-10-16 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +200 | $6.11 | $1K | 547,543 |
| 2025-10-16 | Cloonan Michael President & CEO | Sale 10b5-1 | −200 | $34.00 | $7K | 547,343 |
| 2025-10-16 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −10,225 | 153,142 | ||
| 2025-10-16 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −200 | 152,942 | ||
| 2025-10-15 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +14,775 | $6.11 | $90K | 562,118 |
| 2025-10-15 | Cloonan Michael President & CEO | Sale 10b5-1 | −14,775 | $31.11 | $460K | 547,343 |
| 2025-10-15 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −14,775 | 163,367 | ||
| 2025-10-15 | Booth Bruce Director | Sale 10b5-1 | −65,726 | $30.37 | $2.0M | 2,649,217 |
| 2025-10-15 | Booth Bruce Director | Sale 10b5-1 | −13,795 | $30.37 | $419K | 757,967 |
| 2025-10-15 | Booth Bruce Director | Sale 10b5-1 | −30,032 | $31.12 | $935K | 2,619,185 |
| 2025-10-15 | Booth Bruce Director | Sale 10b5-1 | −6,303 | $31.12 | $196K | 751,664 |
| 2025-10-14 | Booth Bruce Director | Sale 10b5-1 | −501 | $29.95 | $15K | 2,714,943 |
Page 9 of 15 · 284 trades